Symbol
RNA on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Shares Owned
142,888 shares
Security Ownership %
0.1%
Shares, Excluding Options vs Price
Value, Excluding Options

T. Rowe Price Associates, Inc. ownership in Atrium Therapeutics, Inc. Common Stock (RNA)

17 Feb 2026 - T. Rowe Price Associates, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 142,888 shares of Atrium Therapeutics, Inc. Common Stock (RNA). This represents 0.1% ownership of the company. In their previous filing dated 14 Nov 2025, PRICE T ROWE ASSOCIATES INC /MD/ had reported owning 9,787,912 shares, indicating a decrease of +99%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.